Parvinder K Aley Selected Research

COVID-19

12/2023	Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
1/2023	Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
1/2023	Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
11/2022	Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
1/2022	Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.
1/2022	Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
12/2021	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
10/2021	Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
1/2021	Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Parvinder K Aley Research Topics

Disease

14	COVID-19 12/2023 - 01/2020
5	Infections 01/2023 - 01/2021
4	Pain (Aches) 11/2022 - 01/2020
4	Fever (Fevers) 11/2022 - 01/2021
4	Hypoxia (Hypoxemia) 03/2010 - 04/2005
2	Headache (Headaches) 12/2021 - 01/2020
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
1	Meningococcal Infections 12/2022
1	Fatigue 01/2022
1	Asymptomatic Infections 11/2021
1	HIV Infections (HIV Infection) 01/2021
1	Chills 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2013
1	Neointima 11/2008

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 01/2023 - 01/2021
10	ChAdOx1 nCoV-19IBA 01/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
3	MenACWYIBA 12/2022 - 01/2020
3	Nucleic AcidsIBA 10/2021 - 01/2021
2	AntibodiesIBA 12/2023 - 11/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2021
2	COVID-19 VaccinesIBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
1	serogroup C meningococcal conjugate vaccineIBA 12/2022
1	Conjugate VaccinesIBA 12/2022
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	P-2 (P 2)IBA 10/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	ebselenIBA 01/2013
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2013
1	LithiumIBA 01/2013
1	SolutionsIBA 03/2010
1	CopperIBA 03/2010
1	Blood Proteins (Serum Proteins)IBA 03/2010
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 03/2010
1	Cyclic ADP-Ribose (cADPR)IBA 01/2006
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2006
1	Adenosine Triphosphate (ATP)IBA 04/2005
1	RyanodineIBA 04/2005
1	AntioxidantsIBA 04/2005
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2005
1	Inositol (Myoinositol)IBA 04/2005
1	Fura-2 (Fura 2)IBA 04/2005

Therapy/Procedure

1	Intramuscular Injections 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2008
1	Operative Surgical Procedures 11/2008